FASTENAL CO·4

Jun 9, 4:01 PM ET

Papenfuss Donnalee Kathleen 4

4 · FASTENAL CO · Filed Jun 9, 2025

Insider Transaction Report

Form 4
Period: 2025-06-05
Papenfuss Donnalee Kathleen
EVP-Strategy and Communication
Transactions
  • Sale

    Common Stock

    2025-06-05$41.24/sh1,592$65,6500 total
  • Sale

    Common Stock

    2025-06-05$41.30/sh1,364$56,3340 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-06-051,3641,364 total
    Exercise: $13.75Exp: 2027-12-31Common Stock (1,364 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-05$11.75/sh+1,592$18,7061,592 total
  • Exercise/Conversion

    Common Stock

    2025-06-05$13.75/sh+1,364$18,7551,364 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-06-051,5920 total
    Exercise: $11.75Exp: 2026-12-31Common Stock (1,592 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    466
Footnotes (3)
  • [F1]Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 152 (adjusted for stock split on 5/21/2025) shares acquired since the reporting person's Form 3 filed on 11/6/2024.
  • [F2]The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025.
  • [F3]The option will vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two year after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter.

Documents

1 file
  • 4
    wk-form4_1749499281.xmlPrimary

    FORM 4